학술논문
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial
Document Type
Article
Author
Zaman, Azfar; de Winter, Robbert J; Kogame, Norihiro; Chang, Chun Chin; Modolo, Rodrigo; Spitzer, Ernest; Tonino, Pim; Hofma, Sjoerd; Zurakowski, Aleksander; Smits, Pieter C; Prokopczuk, Janusz; Moreno, Raul; Choudhury, Anirban; Petrov, Ivo; Cequier, Angel; Kukreja, Neville; Hoye, Angela; Iniguez, Andrés; Ungi, Imre; Serra, Antonio; Gil, Robert J; Walsh, Simon; Tonev, Gincho; Mathur, Anthony; Merkely, Bela; Colombo, Antonio; Ijsselmuiden, Sander; Soliman, Osama; Kaul, Upendra; Onuma, Yoshinobu; Serruys, Patrick W
Source
The Lancet; March 2019, Vol. 393 Issue: 10175 p987-997, 11p
Subject
Language
ISSN
01406736; 1474547X
Abstract
Supraflex is a sirolimus-eluting stent with a biodegradable polymer coating and ultra-thin struts. We aimed to compare Supraflex with the standard of care, Xience, an everolimus-eluting stent with a durable polymer coating, regarding clinical outcomes with a randomised trial in an all-comer population.